Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-23

Clinical Trial Update: CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes

View source ↗

Summary

This clinical trial evaluates whether CENP-V protein levels in human oocytes can serve as a diagnostic marker of damage from aging or the vitrification/thawing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vida Recoletas Sevilla | Conditions: Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes, Advance Maternal Age | Status: RECRUITING